No Detail Found!

Screening for hepatocellular carcinoma

Author(s)
Tariq Parvez Department of Oncology, King Fahad Hospital, Al-Madina Al-Munawra,Kingdom of Saudi Arabia
Babar Parvez Babar Clinic, Ichra, Lahore, Pakistan
Khurram Pervaiz Pakistan Society for Cancer Prevention, Lahore, Pakistan
Abbass Ali Gumgumj Department of Gastroentrology, KFH, Al-Madina Al-Munawra, KSA
Saleem Al Ahmadi Department of Medicine, KFH, Al-Madina Al-Munawra, KSA
Akbar Ali Sabir Department of Oncology, King Fahad Hospital, Al-Madina Al-Munawra,Kingdom of Saudi Arabia
Fazal Imtiaz Khawaja “Department of Gastroentrology, KFH, Al-Madina Al-Munawra, KSA
Abstract
Liver cancer remains one of the most common causes of cancer death globally, and its cure rate has not improved for the past 20 years. Hepatocellular carcinoma develops in patients with cirrhosis of any etiology. Patients with cirrhosis are thus usually included in screening program aiming to achieve early detection and effective treatment for HCC. Only those patients diagnosed with HCC who would benefit with the available treatment, should undergo the screening procedure. This is based on ultrasonography and alpha-fetoprotein every 3-6 months based on the prevalence and economic status of the community being tested.
Publication Details
Page(s) 570-575
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 14, Issue: 9, Year: 2004

Request the full text from PASTIC

Keywords
Alpha fetoprotein. Ultrasonography. Spiral CT scan. Magnetic resonance imaging. Cirrhosis. Hepatitis C. Hepatitis B.
More from Journal of College of Physicians and Surgeons--Pakistan : JCPSP
0

Citations

0

Downloads

50

Views

Copyright ©  PASTIC National Center, Islamabad www.pastic.gov.pk